Pacemaker infection due to Mycobacterium fortuitum.

Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman. J Clin Microbiol (2007) 0.85

A study of unusual pacemaker infection by mycobacterium tuberculosis in Indian patients. Indian Pacing Electrophysiol J (2014) 0.84

Mycobacterium fortuitum endocarditis associated with cardiac surgery, Serbia. Emerg Infect Dis (2013) 0.81

Successful management of multiple permanent pacemaker complications--infection, 13 year old silent lead perforation and exteriorisation following failed percutaneous extraction, superior vena cava obstruction, tricuspid valve endocarditis, pulmonary embolism and prosthetic tricuspid valve thrombosis. J Cardiothorac Surg (2009) 0.81

Disseminated Mycobacterium chelonae infection causing pacemaker lead endocarditis in an immunocompetent host. BMJ Case Rep (2014) 0.80

Mycobacterial endocarditis: a comprehensive review. Rev Bras Cir Cardiovasc (2015) 0.77

Cardiac implantable electronic device infection due to Mycobacterium species: a case report and review of the literature. BMC Res Notes (2016) 0.75

Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation. Emerg Infect Dis (2016) 0.75

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2007) 11.64

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation (2005) 10.98

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics (2004) 8.10

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68

Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation (2012) 5.25

Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm (2005) 4.39

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis (2003) 3.93

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation (2010) 3.17

Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol (2007) 3.16

Valvular heart disease in patients taking pergolide. Mayo Clin Proc (2002) 3.00

Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation (2012) 2.97

Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA (2005) 2.92

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation (2015) 2.84

Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol (2012) 2.73

Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis (2010) 2.54

Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol (2012) 2.52

Fungal endocarditis, 1995-2000. Chest (2002) 2.52

A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis (2011) 2.50

The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis (2006) 2.37

Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19

Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med (2007) 2.14

Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med (2007) 2.03

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc (2007) 1.98

Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer (2011) 1.80

Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis (2010) 1.79

Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) (2007) 1.75

Pericardial disease: diagnosis and management. Mayo Clin Proc (2010) 1.75

Avian influenza: a new pandemic threat? Mayo Clin Proc (2004) 1.67

Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis (2006) 1.66

Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med (2006) 1.63

Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc (2008) 1.61

Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg (2012) 1.59

A systematic review of population-based studies of infective endocarditis. Chest (2007) 1.59

Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis (2006) 1.58

Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet (2003) 1.58

Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol (2011) 1.57

Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation (2011) 1.54

Dyssynchrony indices to predict response to cardiac resynchronization therapy: a comprehensive prospective single-center study. Circ Heart Fail (2010) 1.52

Risk factor analysis of permanent pacemaker infection. Clin Infect Dis (2007) 1.51

Propensity score analysis with a time-dependent intervention is an acceptable although not an optimal analytical approach when treatment selection bias and survivor bias coexist. J Clin Epidemiol (2009) 1.51

Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc (2008) 1.51

Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch block. Circulation (2008) 1.50

Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional study. BMC Public Health (2011) 1.50

Bronchoscopy in ventilator-associated pneumonia: agreement of calibrated loop and serial dilution. Am J Respir Crit Care Med (2006) 1.47

Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (2010) 1.45

Strain dyssynchrony index correlates with improvement in left ventricular volume after cardiac resynchronization therapy better than tissue velocity dyssynchrony indexes. Circ Cardiovasc Imaging (2008) 1.44

Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience. J Cardiovasc Electrophysiol (2007) 1.43

Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace (2012) 1.40

Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. Cochrane Database Syst Rev (2014) 1.39

Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol (2006) 1.36

Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol (2011) 1.36

The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis (2013) 1.36

Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses (2010) 1.31

Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect (2005) 1.31

Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28

Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med (2008) 1.28

Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg (2013) 1.27

Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother (2009) 1.27

Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J (2008) 1.26

Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace (2013) 1.24

An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol (2012) 1.21

Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol (2012) 1.20

Clostridium difficile infection in patients with chronic kidney disease. Mayo Clin Proc (2012) 1.18

Systematic reviewers commonly contact study authors but do so with limited rigor. J Clin Epidemiol (2008) 1.17

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc (2008) 1.17

Surgical site infection after breast surgery: impact of 2010 CDC reporting guidelines. Ann Surg Oncol (2012) 1.15

Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J (2008) 1.15

Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm (2011) 1.15

Trends in Infective Endocarditis Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011: The Devil Is in the Details. J Am Coll Cardiol (2015) 1.12

Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology (2011) 1.11

Cutaneous inoculation blastomycosis. Clin Infect Dis (2002) 1.11

Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis (2003) 1.10

Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother (2009) 1.10

Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis (2013) 1.10

The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation (2007) 1.09

Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis (2009) 1.09

Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc (2010) 1.08

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis (2007) 1.08

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One (2012) 1.08

The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J (2008) 1.07

Early cardiac surgery after ischemic stroke in patients with infective endocarditis may not be safe. Clin Infect Dis (2013) 1.07

Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis (2009) 1.06

A novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int (2014) 1.06

Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead. Heart (2013) 1.06